Results 191 to 200 of about 150,034 (233)

Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers   +19 more
wiley   +1 more source

Electroencephalographic Normalization as a Biomarker of Clinical Recovery in Down Syndrome Regression Disorder

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Down syndrome regression disorder is a syndrome characterized by subacute loss of cognitive, behavioral, and functional abilities in individuals with Down syndrome. Electroencephalography abnormalities are frequently observed during evaluation, but it remains unclear whether these findings represent a dynamic marker of disease ...
Jonathan D. Santoro   +14 more
wiley   +1 more source

The Eurostack of digital health cybersecurity. [PDF]

open access: yesFront Digit Health
Brightwell C, Carboni C, Halpern O.
europepmc   +1 more source

State-Funded Health Insurance Expansion for Noncitizen Immigrants and Hospital Uncompensated Care.

open access: yesJAMA Netw Open
Martinez-Cardoso A   +4 more
europepmc   +1 more source

Health System Policies Following State Abortion Restrictions in the US.

open access: yesJAMA Netw Open
Shadow L   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy